YIFAN PHARMACEUTIC

002019 SZSE
002019
YIFAN PHARMACEUTIC SZSE
 
Prossimi utili
EPS
Cap. di mercato
Div yield
P/E
Prossimi utili
EPS
Cap. di mercato
Div yield
P/E

Report finanziari 002019

I conti di YIFAN PHARMACEUTIC, comprensivi di fatturato, spese, profitti e perdite

The total revenue of 002019 for the last quarter is 1.01B CNY, and it's 13.27% lower compared to the previous quarter. The net income of Q3 21 is 77.62M CNY.

TTM
Utile lordo
Totale ricavi
Cost of goods sold
Spese operative (escl. COGS)
Utile operativo
Non-operating income, total
Pretax income
Equity in earnings
Taxes
Non-controlling/minority interest
After tax other income/expense
Net income before discontinued operations
Discontinued operations
Utile netto
Dilution adjustment
Preferred dividends
Diluted net income available to common stockholders
Basic earnings per share (Basic EPS)
Diluted earnings per share (Diluted EPS)
Average basic shares outstanding
Diluted shares outstanding
EBITDA
EBIT
Totale spese operative